Alsomali N, Alsharif R, Albalawi B, Alharthi R, Junaidallah W, Alshammari S, Alhawiti F, Alenezi A, Alarieh R, Alsaeed W, AlTowaijri G
Research Centre, Neuroscience Department, King Fahad Medical City, Riyadh, Saudi Arabia.
Tabuk University, Tabuk, Saudi Arabia.
Metabol Open. 2022 Mar 24;14:100181. doi: 10.1016/j.metop.2022.100181. eCollection 2022 Jun.
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. It is an autoimmune disease of multifactorial etiology, linked to a variety of genetic and well-defined environmental factors. It typically affects more women than men and more frequently affects adults aged 20-45 years. Besides, vitamin B12 deficiency and obesity are associated with exacerbating central nervous system inflammation and a higher clinical disability.
The study aims to determine the association of the vitamin B12 serum concentration with the Body Mass Index BMI, thyroid-stimulating hormone serum levels and MS clinical features in Saudi MS patients.
This is a retrospective cohort study, and data were collected from the MS database at the King Fahad Medical City Multiple Sclerosis Clinic, from December 2015 to December 2019. Data were entered and analyzed using the Statistical Package for Social Sciences (SPSS ver. 20, Chicago, IL, USA). Cobalamin, also known as vitamin B12, has a reference concentration that ranges from 138 to 652 Pmol/L in adults. The patient's BMI was calculated by dividing the weight (in kilograms) by the square of the height (in square meters), expressed in kg/m.Data for 169 MS subjects were collected. A total 83 of them, with a mean age of 36.2 ± 9.57 years, had vitamin B12 results. Of all patients, 16.6% had vitamin B12 deficiency (<138 pmol/L) and 9.52% of them were overweight, BMI kg/m = (25-29.9). The mean vitamin B12 level in all MS subjects was 240 ± 117 pmol/L. Moreover, 58.33% of the MS patients had high BMIs (BMI >25). However, no significant correlation was found between vitamin B12 deficiency neither with the BMI nor TSH concentration in MS cases (r = 0.03, p = 0.64), (r = 0.00, P = 0.9) respectively.
These findings revealed no association between serum vitamin B12 concentration and TSH, BMI in MS clinical parameters, however, further studies are required to validate these results.
多发性硬化症(MS)是一种中枢神经系统的慢性炎症性脱髓鞘疾病。它是一种病因多因素的自身免疫性疾病,与多种遗传因素和明确的环境因素有关。女性比男性更易受影响,且在20 - 45岁的成年人中更为常见。此外,维生素B12缺乏和肥胖与中枢神经系统炎症加剧及更高的临床残疾率相关。
本研究旨在确定沙特多发性硬化症患者血清维生素B12浓度与体重指数(BMI)、促甲状腺激素血清水平及MS临床特征之间的关联。
这是一项回顾性队列研究,数据收集自2015年12月至2019年12月法赫德国王医疗城多发性硬化症诊所的MS数据库。使用社会科学统计软件包(SPSS 20.0版,美国伊利诺伊州芝加哥)录入和分析数据。钴胺素,即维生素B12,在成年人中的参考浓度范围为138至652皮摩尔/升。患者的BMI通过体重(千克)除以身高的平方(平方米)计算得出,单位为kg/m²。收集了169名MS受试者的数据。其中83人有维生素B12检测结果,平均年龄为36.2±9.57岁。所有患者中,16.6%存在维生素B12缺乏(<138皮摩尔/升),9.52%超重,BMI为kg/m² =(25 - 29.9)。所有MS受试者的平均维生素B12水平为240±117皮摩尔/升。此外,58.33%的MS患者BMI较高(BMI>25)。然而在MS病例中,维生素B12缺乏与BMI及促甲状腺激素浓度之间均未发现显著相关性(r = 0.03,p = 0.64),(r = 0.00,P = 0.9)。
这些发现表明血清维生素B12浓度与MS临床参数中的促甲状腺激素、BMI之间无关联,不过仍需进一步研究来验证这些结果。